Literature DB >> 21138397

Mitochondrial perturbance and execution of apoptosis in platelet mitochondria of patients with amyotrophic lateral sclerosis.

Mohita Shrivastava1, S Vivekanandhan, Uttam Pati, Madhuri Behari, Taposh K Das.   

Abstract

Role of platelets have been evinced as a systemic tool in a variety of neurological disorders. Oxidative phosphorylation contributes approximately 80% of total adenosine-tri-phosphate (ATP) production in resting platelets suggesting potential dependence of platelets on modest mitochondrial functioning. Since mitochondria play a pivotal role in regulating metabolic and apoptotic pathways in various neurodegenerative disorders including amyotrophic lateral sclerosis (ALS), we assessed mitochondrial membrane potential (MMP) associated alterations and apoptotic status of platelet mitochondria in ALS patients using case-control approach. Confocal microscopy reflected heterogeneous distribution of JC-1 aggregates and monomers indicating altered MMP in ALS platelets. Our flow cytometry results confirmed greater percentage of mitochondrial depolarization in ALS platelets. Greater exposure of phosphatidyl serine (PS) residue vindicated by annexin V binding and lesser accumulation of mitotracker red in mitochondrial matrix demonstrated initiation of apoptosis in ALS platelets. Our findings corroborate mitochondrial abnormalities such as perturbance of MMP, mitochondrial depolarization, and apoptosis in ALS platelet mitochondria. In conclusion, our study further evinces the involvement of mitochondrial dysfunction in the pathogenesis of ALS and suggests implication of cell death in peripheral tissues apart from motor neurons in ALS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21138397     DOI: 10.3109/00207454.2010.537416

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  12 in total

1.  Vamping: stereology-based automated quantification of fluorescent puncta size and density.

Authors:  Dani Dumitriu; Seth I Berger; Carine Hamo; Yuko Hara; Megan Bailey; Amarelle Hamo; Yael S Grossman; William G Janssen; John H Morrison
Journal:  J Neurosci Methods       Date:  2012-06-07       Impact factor: 2.390

2.  A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement.

Authors:  Zachary Macchi; Yunxia Wang; Dan Moore; Jonathan Katz; David Saperstein; David Walk; Ericka Simpson; Angela Genge; Tulio Bertorini; J Americo Fernandes; Andrea Swenson; Lauren Elman; Mazen Dimachkie; Laura Herbelin; Joann Miller; Jianghua Lu; Heather Wilkins; Russell H Swerdlow; Jeffrey Statland; Richard Barohn
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-04-02       Impact factor: 4.092

3.  Mitochondrial dysfunction in blood cells from amyotrophic lateral sclerosis patients.

Authors:  Johannes K Ehinger; Saori Morota; Magnus J Hansson; Gesine Paul; Eskil Elmér
Journal:  J Neurol       Date:  2015-04-18       Impact factor: 4.849

Review 4.  New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.

Authors:  Heather M Wilkins; Jill K Morris
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 5.  Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies.

Authors:  Francisco J Carvajal; Hayley A Mattison; Waldo Cerpa
Journal:  Neural Plast       Date:  2016-08-18       Impact factor: 3.599

Review 6.  Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration.

Authors:  Heather M Wilkins; Ian W Weidling; Yan Ji; Russell H Swerdlow
Journal:  Front Immunol       Date:  2017-04-26       Impact factor: 7.561

7.  Hypoxic mitophagy regulates mitochondrial quality and platelet activation and determines severity of I/R heart injury.

Authors:  Weilin Zhang; He Ren; Chunling Xu; Chongzhuo Zhu; Hao Wu; Dong Liu; Jun Wang; Lei Liu; Wei Li; Qi Ma; Lei Du; Ming Zheng; Chuanmao Zhang; Junling Liu; Quan Chen
Journal:  Elife       Date:  2016-12-20       Impact factor: 8.140

Review 8.  Platelets in Neurodegenerative Conditions-Friend or Foe?

Authors:  Odette Leiter; Tara L Walker
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

9.  Platelet microRNA-15b protects against high platelet reactivity in patients undergoing percutaneous coronary intervention through Bcl-2-mediated platelet apoptosis.

Authors:  Jinghan Wang; Yi Yao; Jiahui Zhang; Xiaofang Tang; Xianmin Meng; Miao Wang; Lei Song; Jinqing Yuan
Journal:  Ann Transl Med       Date:  2020-03

Review 10.  7-Ketocholesterol in disease and aging.

Authors:  Amelia Anderson; Angielyn Campo; Elena Fulton; Anne Corwin; W Gray Jerome; Matthew S O'Connor
Journal:  Redox Biol       Date:  2019-11-14       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.